ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ANNX Annexon Inc

5.10
0.44 (9.44%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Annexon Inc ANNX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.44 9.44% 5.10 13:00:04
始値 安値 高値 終値 前日終値
4.75 4.69 5.06 4.88 4.66
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1622:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
2024/2/2206:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2206:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2206:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2105:15EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2105:12EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1510:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1509:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1509:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1509:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1505:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1409:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1408:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1306:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1305:45EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1305:41EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1305:39EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2407:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2024/1/2406:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0906:09EDGAR2Form 8-K - Current report
2024/1/0810:00GLOBEAnnexon Outlines 2024 Priorities with Late-Stage Clinical..
2023/12/3006:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2806:50EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2720:30GLOBEAnnexon Biosciences to Present at the 42nd Annual J.P...
2023/12/2307:28EDGAR2Form 8-K/A - Current report: [Amend]
2023/12/2206:09EDGAR2Form 8-K - Current report
2023/12/2206:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/2107:27GLOBEAnnexon Announces Pricing of $125.0 Million Underwritten..
2023/12/2107:24EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2023/12/2107:17EDGAR2Form 8-K - Current report
2023/12/2107:10GLOBEAnnexon Outlines Global Registrational Program for ANX007 in..
2023/12/2107:08GLOBEAnnexon Reports Phase 1 Results for ANX1502, its Oral Small..
2023/12/1906:01GLOBEAnnexon Reports Inducement Grants to New Employees Under..
2023/11/2306:01GLOBEAnnexon Biosciences to Participate in the 6th Annual..
2023/11/1406:10EDGAR2Form 8-K - Current report
2023/11/1320:30GLOBEAnnexon Reports Significant Progress with its Priority..
2023/11/0920:30GLOBEAnnexon Biosciences to Participate in 2023 Jefferies London..
2023/10/2505:30EDGAR2Form 8-K - Current report
2023/10/2419:30GLOBEAnnexon Receives PRIME Designation from the EMA for ANX007..
2023/10/1905:01GLOBEAnnexon Reports Inducement Grants to New Employees Under..
2023/10/1205:44EDGAR2Form 8-K - Current report
2023/10/1019:30GLOBEAnnexon Announces Clinical and Regulatory Progress for..
2023/9/1919:30GLOBEAnnexon Biosciences to Participate in the 2023 Cantor Global..
2023/9/1905:01GLOBEAnnexon Reports Inducement Grant to New Employee Under..
2023/8/0805:12EDGAR2Form 8-K - Current report
2023/8/0805:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0719:30GLOBEAnnexon Highlights Recent Pipeline and Business Progress and..
2023/8/0306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0306:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/0305:01GLOBEAnnexon Reports Inducement Grant to New Employee Under..

最近閲覧した銘柄

Delayed Upgrade Clock